Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks.
Journal
JAMA dermatology
ISSN: 2168-6084
Titre abrégé: JAMA Dermatol
Pays: United States
ID NLM: 101589530
Informations de publication
Date de publication:
01 01 2019
01 01 2019
Historique:
pubmed:
30
11
2018
medline:
15
10
2019
entrez:
29
11
2018
Statut:
ppublish
Résumé
Convolutional neural networks (CNNs) achieve expert-level accuracy in the diagnosis of pigmented melanocytic lesions. However, the most common types of skin cancer are nonpigmented and nonmelanocytic, and are more difficult to diagnose. To compare the accuracy of a CNN-based classifier with that of physicians with different levels of experience. A CNN-based classification model was trained on 7895 dermoscopic and 5829 close-up images of lesions excised at a primary skin cancer clinic between January 1, 2008, and July 13, 2017, for a combined evaluation of both imaging methods. The combined CNN (cCNN) was tested on a set of 2072 unknown cases and compared with results from 95 human raters who were medical personnel, including 62 board-certified dermatologists, with different experience in dermoscopy. The proportions of correct specific diagnoses and the accuracy to differentiate between benign and malignant lesions measured as an area under the receiver operating characteristic curve served as main outcome measures. Among 95 human raters (51.6% female; mean age, 43.4 years; 95% CI, 41.0-45.7 years), the participants were divided into 3 groups (according to years of experience with dermoscopy): beginner raters (<3 years), intermediate raters (3-10 years), or expert raters (>10 years). The area under the receiver operating characteristic curve of the trained cCNN was higher than human ratings (0.742; 95% CI, 0.729-0.755 vs 0.695; 95% CI, 0.676-0.713; P < .001). The specificity was fixed at the mean level of human raters (51.3%), and therefore the sensitivity of the cCNN (80.5%; 95% CI, 79.0%-82.1%) was higher than that of human raters (77.6%; 95% CI, 74.7%-80.5%). The cCNN achieved a higher percentage of correct specific diagnoses compared with human raters (37.6%; 95% CI, 36.6%-38.4% vs 33.5%; 95% CI, 31.5%-35.6%; P = .001) but not compared with experts (37.3%; 95% CI, 35.7%-38.8% vs 40.0%; 95% CI, 37.0%-43.0%; P = .18). Neural networks are able to classify dermoscopic and close-up images of nonpigmented lesions as accurately as human experts in an experimental setting.
Identifiants
pubmed: 30484822
pii: 2716294
doi: 10.1001/jamadermatol.2018.4378
pmc: PMC6439580
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
58-65Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Br J Dermatol. 2011 Apr;164(4):797-806
pubmed: 21294715
Arch Dermatol. 2005 Nov;141(11):1388-96
pubmed: 16301386
Cancer Res. 2012 May 15;72(10):2491-500
pubmed: 22434431
Exp Dermatol. 2018 Nov;27(11):1261-1267
pubmed: 30187575
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
JAMA. 2018 Jun 12;319(22):2267-2268
pubmed: 29800012
PLoS One. 2018 Mar 7;13(3):e0193321
pubmed: 29513718
Australas J Dermatol. 2011 Feb;52(1):76-8
pubmed: 21332701
Br J Dermatol. 2014 Nov;171(5):1099-107
pubmed: 24841846
J Am Acad Dermatol. 2017 Dec;77(6):1100-1109
pubmed: 28941871
JAMA Dermatol. 2017 May 1;153(5):453-457
pubmed: 28241182
J Am Acad Dermatol. 2018 Feb;78(2):270-277.e1
pubmed: 28969863
AMIA Annu Symp Proc. 2007 Oct 11;:191-5
pubmed: 18693824
Arch Dermatol. 2008 Sep;144(9):1120-7
pubmed: 18794455
Melanoma Res. 2000 Dec;10(6):556-61
pubmed: 11198477
J Am Acad Dermatol. 2012 Jul;67(1):54-9
pubmed: 21982636
J Am Acad Dermatol. 2016 Jun;74(6):1093-106
pubmed: 26896294
IEEE J Biomed Health Inform. 2018 Apr 09;:
pubmed: 29993994
Skin Res Technol. 2018 May;24(2):256-264
pubmed: 29057507
Int J Cancer. 2002 Oct 20;101(6):576-80
pubmed: 12237900
Br J Dermatol. 2017 Sep;177(3):867-869
pubmed: 28569993
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Br J Dermatol. 1994 Apr;130(4):460-5
pubmed: 8186110
J Invest Dermatol. 2018 Jul;138(7):1529-1538
pubmed: 29428356
Ann Oncol. 2018 Aug 1;29(8):1836-1842
pubmed: 29846502
J Am Acad Dermatol. 2011 Jun;64(6):1068-73
pubmed: 21440329
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
J Am Acad Dermatol. 2004 May;50(5):683-9
pubmed: 15097950